Daphne Friedman
Hematology & Oncology · Durham, NCNPI 1356515043
Payments from drug & device makers
$437,618in general payments, 2019–2025
Across 197 payments — averaging $2221.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$256K
- TG Therapeutics, Inc.$105K
- Eli Lilly$57K
- Amgen$20K
- AstraZeneca$43
- Karyopharm Therapeutics Inc.$12
What the payments were for
- Education$56100%
General payments by program year
20
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 164 | $256,033 |
| TG Therapeutics, Inc. | 20 | $104,596 |
| Eli Lilly | 9 | $57,365 |
| Amgen | 2 | $19,569 |
| AstraZeneca | 1 | $43 |
| Karyopharm Therapeutics Inc. | 1 | $12 |
How this compares
$437,618 in reported general payments places this provider in the 80th percentile of 358 hematology & oncology providers in North Carolina.
Other hematology & oncology in Durham
- Kimberly BlackwellDurham$13.2M
- Danielle BranderDurham$8.6M
- Michael MorseDurham$6M
- Jameel MuzaffarDurham$3.5M
- Matthew McKinneyDurham$2.9M
- Andrea SitlingerDurham$2M
- Kimberly WymanDurham$1.5M
- Syed ZafarDurham$978K
- Soheir AdamDurham$855K
- Yubin KangDurham$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.